NumerixS Investment Technologies’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-599
| Closed | -$47K | – | 658 |
|
|
2020
Q2 | $47K | Buy |
+599
| New | +$47K | 0.01% | 806 |
|
|
2019
Q3 | – | Sell |
-400
| Closed | -$25K | – | 1189 |
|
|
2019
Q2 | $25K | Buy |
+400
| New | +$25K | 0.01% | 886 |
|
|
2018
Q2 | – | Sell |
-200
| Closed | -$10K | – | 1317 |
|
|
2018
Q1 | $10K | Buy |
+200
| New | +$10K | ﹤0.01% | 981 |
|
|
2017
Q4 | – | Sell |
-5,300
| Closed | -$282K | – | 1318 |
|
|
2017
Q3 | $282K | Sell |
5,300
-1,200
| -18% | -$63.8K | 0.06% | 400 |
|
|
2017
Q2 | $404K | Sell |
6,500
-3,900
| -38% | -$242K | 0.06% | 403 |
|
|
2017
Q1 | $705K | Buy |
+10,400
| New | +$705K | 0.08% | 302 |
|
|
2016
Q4 | – | Sell |
-3,700
| Closed | -$262K | – | 1298 |
|
|
2016
Q3 | $262K | Sell |
3,700
-8,500
| -70% | -$602K | 0.03% | 601 |
|
|
2016
Q2 | $597K | Buy |
+12,200
| New | +$597K | 0.08% | 341 |
|
|
2016
Q1 | – | Sell |
-2,551
| Closed | -$286K | – | 946 |
|
|
2015
Q4 | $286K | Sell |
2,551
-6,500
| -72% | -$729K | 0.04% | 596 |
|
|
2015
Q3 | $872K | Buy |
+9,051
| New | +$872K | 0.1% | 255 |
|